Protalix BioTherapeutics Inc (PLX)
1.78
+0.05
(+2.89%)
USD |
NYAM |
Dec 24, 16:00
Protalix BioTherapeutics Gross Profit (Annual): 42.51M for Dec. 31, 2023
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Accuray Inc | 142.92M |
| AIM ImmunoTech Inc | 0.16M |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 41.73M |
| Armata Pharmaceuticals Inc | -- |